-transparent.png){kind=logo}
The anti-tumour activity of Lactobacillus casei YIT 9018 (LC 9018) on Lewis lung carcinoma (3LL) in C57BL/6 mice and line-10 hepatoma in strain-2 guinea pigs was examined. Intravenous injection of LC 9018 was effective for inhibition of pulmonary metastases in C57BL/6 mice after s.c. inoculation with 3LL tumours. Intralesional (i.l.) injection of LC 9018 was also effective for both prolongation of the survival period and inhibition of pulmonary metastases in 3LL tumour-bearing mice. The combination treatment of i.l. and i.v. injections of LC 9018 before or after surgical excision of the primary tumour remarkably inhibited the pulmonary metastases after inoculation with 3LL tumour. Intralesional injection of LC 9018 was effective for regression of the established tumours of line-10 hepatoma inoculated i.d. and for induction of systemic tumour immunity in strain-2 guinea pigs.
T Matsuzaki, and
T Yokokura, and
I Azuma
January 1994,
Proceedings of the Western Pharmacology Society,
T Matsuzaki, and
T Yokokura, and
I Azuma
January 1986,
Methods and findings in experimental and clinical pharmacology,
T Matsuzaki, and
T Yokokura, and
I Azuma
January 1979,
Journal of the National Cancer Institute,
T Matsuzaki, and
T Yokokura, and
I Azuma
August 1981,
Gan,
T Matsuzaki, and
T Yokokura, and
I Azuma
February 1997,
International journal of food microbiology,
T Matsuzaki, and
T Yokokura, and
I Azuma
March 1995,
Scandinavian journal of immunology,
T Matsuzaki, and
T Yokokura, and
I Azuma
October 1979,
Proceedings of the National Academy of Sciences of the United States of America,
T Matsuzaki, and
T Yokokura, and
I Azuma
December 1979,
The Australian journal of experimental biology and medical science,
T Matsuzaki, and
T Yokokura, and
I Azuma
January 1985,
Cancer immunology, immunotherapy : CII,
T Matsuzaki, and
T Yokokura, and
I Azuma
January 1984,
Gan,
